Latest news
Join Biovie's Exclusive Live Investor Webinar: Inside the SUNRISE-PD Topline Results - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:00:00 GMTBioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 11:30:00 GMTBioVie reports positive Phase 2 results for Parkinson's candidate bezisterim - Proactive InvestorsProactive Investors · Thu, 06 Aug 2026 09:03:00 GMT